vimarsana.com

Latest Breaking News On - Hemophilia center - Page 5 : vimarsana.com

FDA approves $2 9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

FDA approves $2 9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

FDA approves $2 9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

FDA approves $2 9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

FDA approves $2 9 million gene therapy for severe hemophilia

Roctavian is an infusion that's been shown to reduce dangerous bleeding problems caused by the inherited condition.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.